Upcoming Financial Results Conference Call
Beyond Air, Inc. (NASDAQ: XAIR), based in Garden City, New York, is excited to announce its upcoming financial results for the first fiscal quarter that ended on June 30, 2025. The company has scheduled a conference call and webcast to take place on the date of August 12, 2025, at 4:30 p.m. Eastern Time. Investors and stakeholders are encouraged to participate in this informative event as the management team shares insights and discusses the financial performance.
Details of the Conference Call
The conference call will provide an in-depth look at the financial data, along with updates on the advancements and progress being made at Beyond Air. Interested participants can join the call using the following contact numbers:
Domestic Calls: 1-877-407-0784
International Calls: 1-201-689-8560
Make sure to mention the Conference ID: 13754769 when prompted, to ensure smooth access to the call.
Accessing the Webcast
A live webcast of this conference call will also be available through the Events section of the company’s official website. Participants can expect an online replay of the call to be accessible shortly after its conclusion, ensuring that those who are unable to attend live won't miss out on critical information.
About Beyond Air, Inc.
Beyond Air, Inc. is a dedicated commercial-stage medical device and biopharmaceutical company that focuses on utilizing nitric oxide (NO) to enhance patient outcomes. The company is particularly engaged in improving treatments for patients suffering from respiratory illnesses, neurological conditions, and various types of solid tumors. With a commitment to innovation, Beyond Air has successfully received FDA approval and CE Mark for its first system, LungFit® PH, designed for treating neonates facing hypoxic respiratory failure. Furthermore, the company is progressing with additional LungFit systems currently under clinical trials aimed at severe lung infections, including viral pneumonia, which is notably crucial given the ongoing concerns surrounding COVID-19.
Collaborations and Future Developments
In addition to ongoing product developments, Beyond Air has collaborated with The Hebrew University of Jerusalem to further research treatments for autism spectrum disorder (ASD) and other neurological disorders. The commitment to advancing healthcare solutions is evident in their efforts as Beyond Cancer, an affiliate, looks into utilizing ultra-high concentrations of NO to treat certain solid tumors in a pre-clinical environment.
Company Contact Information
For inquiries related to the upcoming conference call or details about Beyond Air, interested parties can reach out to:
Corey Davis, Ph.D.
LifeSci Advisors, LLC
Email: Cdavis@lifesciadvisors.com
Phone: (212) 915-2577
Frequently Asked Questions
What is the date of Beyond Air's upcoming financial results call?
The financial results call is scheduled for August 12, 2025.
What time will the conference call begin?
The conference call starts at 4:30 PM Eastern Time.
How can I access the live webcast of the conference?
You can access the live webcast through the Events section of Beyond Air's website.
What is the focus of Beyond Air, Inc.?
Beyond Air is focused on developing medical devices and biopharmaceutical solutions utilizing nitric oxide for treating respiratory and neurological conditions.
Who can I contact for more information?
You can contact Corey Davis, Ph.D., at LifeSci Advisors for more details about the company and the upcoming event.
